The Effect of Insoles in Plantar Fasciitis
Launched by MEDIPOL UNIVERSITY · Aug 19, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how two types of personalized insoles can help people with plantar fasciitis, a condition that causes pain in the heel and bottom of the foot. The goal is to see if these insoles, made from different materials, can reduce pain and improve walking and muscle activity over a three-month period.
To participate in this study, you need to be between 18 and 65 years old, have been diagnosed with plantar fasciitis, and have been experiencing pain for at least three months, especially when taking your first steps in the morning or after resting. The study is not yet recruiting participants, but if you qualify, you can expect to try out the insoles and have your pain and walking patterns monitored. It’s important to note that certain health conditions or past surgeries may prevent you from joining. This trial could potentially lead to better treatment options for plantar fasciitis, helping many people find relief from their foot pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being between the ages of 18-65,
- • Being diagnosed with plantar fasciitis,
- • Being prescribed custom insoles,
- • Having complaints for at least 3 months,
- • Heel pain complaint is at the plantar medial calcaneal tubercle,
- • Pain complaint is most evident in the first steps taken in the morning or in the steps after resting,
- • Having a Roles and Maudsley score of 3 or 4 in the initial evaluation
- Exclusion Criteria:
- • Having a body mass index greater than 30 kg/m2,
- • Having any cardiopulmonary, dermatological, neurological or orthopedic problems other than plantar fasciitis,
- • Having a history of foot or ankle surgery,
- • Using an assistive device (walker, canadiens, etc.)
- • Not using appropriate shoes,
- • Having cognitive, mental and/or psychological problems
- • Being pregnant
About Medipol University
Medipol University is a leading academic institution dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts rigorous clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Leveraging state-of-the-art facilities and a team of experienced researchers and healthcare professionals, Medipol University is committed to contributing to the global medical community through ethical research and the development of novel therapeutic strategies. The institution fosters an environment of academic excellence and integrity, ensuring that all trials adhere to the highest standards of safety and efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported